Jessilin Quint, OD, MS, MBA, FAAO; and Marjan Farid, MD
Show Description +
Marjan Farid, MD, and Jessilin Quint, OD, MS, MBA, FAAO, share why this is an exciting time for patients with presbyopia after the launch of Qlosi™ (pilocarpine hydrochloride ophthalmic solution) 0.4% (Orasis Pharmaceuticals Inc.). They describe how this safe and effective treatment allows patients to achieve improved near vision without compromising distance.
Posted: 7/30/2025
Jessilin Quint, OD, MS, MBA, FAAO; and Marjan Farid, MD
Marjan Farid, MD, and Jessilin Quint, OD, MS, MBA, FAAO, share why this is an exciting time for patients with presbyopia after the launch of Qlosi™ (pilocarpine hydrochloride ophthalmic solution) 0.4% (Orasis Pharmaceuticals Inc.). They describe how this safe and effective treatment allows patients to achieve improved near vision without compromising distance.
Posted: 7/30/2025
About Orasis Pharmaceuticals
ORASIS (OR-uh-sis) Pharmaceuticals is an emerging ophthalmic pharmaceutical company, with offices in the US and Israel, focused on developing an innovative solution for the treatment of presbyopia symptoms. Orasis’ novel proprietary formulation of low dose pilocarpine and a proprietary vehicle was purposefully designed with the patient in mind to achieve an optimal balance among efficacy, safety, and comfort.
The name Orasis has its roots in the Greek language, where it carries a literal translation of “good vision or sight.” Beyond this, however, as good vision in its positive mental/philosophical meaning — and this speaks to our aspiration as a company to develop pharmaceutical drugs that improve vision and quality of life for millions of people around the world.
Visit us online: orasis-pharma.com
Follow Orasis Pharmaceuticals